The us propylene glycol market grew from USD 1.16 Million in 2025 to USD 1.22 Million in 2026 and is projected to reach USD 1.83 Million by 2034, growing at a CAGR of 4.88% during 2026-2034. The market is driven by expanding pharmaceutical applications, growing antifreeze demand, and rising adoption of bio-based propylene glycol.
Petroleum-based propylene glycol commands 91.6% of the us glycol market. Antifreeze and functional fluids lead applications at 31.7%. The South region accounts for 42.8% of national consumption, anchored by Gulf Coast petrochemical manufacturing infrastructure.
|
Metric |
Value |
|
Base Year Market Size (2025) |
USD 1.16 Million |
|
Market Size (2026) |
USD 1.22 Million |
|
Forecast Market Size (2034) |
USD 1.83 Million |
|
CAGR (2026-2034) |
4.88% |
|
Base Year |
2025 |
|
Historical Period |
2020-2025 |
|
Forecast Period |
2026-2034 |
|
Dominant Source |
Petroleum-based (91.6%, 2025) |
|
Dominant Application |
Antifreeze & Functional Fluids (31.7%, 2025) |
|
Leading Region |
South (42.8%, 2025) |
The US propylene glycol market grew from USD 0.92 Million in 2020 to USD 1.16 Million in 2025. The market is projected to reach USD 1.22 Million in 2026, USD 1.48 Million in 2030, and USD 1.83 Million by 2034.

To get more information on this market, Request Sample
Bio-based propylene glycol registers the fastest CAGR of ~7.2%, driven by USDA BioPreferred mandates and corporate ESG targets. Food, drug, and cosmetics applications grow at ~5.8% CAGR through pharmaceutical sector expansion.

The United States propylene glycol market reached USD 1.16 Million in 2025 and is estimated to reach USD 1.22 Million in 2026. The market is positioned at the intersection of petrochemical manufacturing, regulated food and pharmaceutical applications, and emerging bio-based chemistry.
Petroleum-based propylene glycol commands 91.6% market share, supported by established propylene oxide production infrastructure on the Gulf Coast. The South leads regionally at 42.8%, anchored by petrochemical production capacity in Texas and Louisiana.
The market is projected to reach USD 1.83 Million by 2034, supported by pharmaceutical manufacturing growth, EV thermal management applications, and continued antifreeze and functional fluid demand.
|
Insight |
Data |
|
Dominant Source |
Petroleum-based - 91.6% (2025) |
|
Dominant Application |
Antifreeze & Functional Fluids - 31.7% (2025) |
|
Leading Region |
South - 42.8% (2025) |
|
Key Market Opportunity |
Bio-based expansion; pharmaceutical-grade demand; EV thermal management; sustainable ingredient sourcing |
- Petroleum-based at 91.6%: Petroleum-based propylene glycol dominates through cost efficiency, established production infrastructure, and versatile applicability across all grades. Propylene oxide hydrolysis remains the primary commercial production route, supporting high-volume output and competitive pricing at industrial scale.
- Antifreeze and Functional Fluids at 31.7%: The transportation and aviation sectors drive sustained propylene glycol demand through coolant, de-icing fluid, and HVAC heat transfer applications. The US vehicle fleet of over 290 million registered vehicles and commercial aviation operations collectively underpin structural demand for this leading application segment.
- South at 42.8%: Gulf Coast petrochemical production concentration in Texas and Louisiana creates both supply capacity and downstream industrial demand. The region hosts major propylene glycol manufacturing facilities and serves as the primary national distribution hub for industrial and commercial buyers.
The US propylene glycol market is commercially structured around three distinct quality tiers: industrial-grade, food-grade, and pharmaceutical-grade. Each tier operates under different regulatory requirements and commands distinct pricing. FDA, EPA, and USDA BioPreferred regulations define the quality standards governing each tier.

The us bio-based propylene glycol market is gaining commercial traction within this tiered structure, with USDA BioPreferred certification enabling market access to federal procurement and corporate sustainability-mandated supply chains. The bio-based segment differentiates on renewable sourcing and sustainability credentials.

To evaluate market opportunities, Request Sample

Bio-based propylene glycol from glycerol and other renewable feedstocks is gaining commercial traction through USDA BioPreferred mandates and corporate sustainability commitments. Demand from personal care and food processing companies seeking green-certified ingredients is accelerating adoption and investment in bio-based capacity.
The US transition to electric vehicles generates structured demand for propylene glycol in battery cooling and thermal management systems. EV manufacturers require non-toxic heat transfer fluids with precise thermal properties, creating a premium application niche growing in tandem with the expanding domestic EV production base.
US government initiatives to reshore pharmaceutical manufacturing are increasing domestic production of medicines, vaccines, and drug formulations. Propylene glycol, as a critical pharmaceutical excipient, benefits directly from this structural shift toward domestic drug manufacturing capacity across multiple dosage forms.
The US aviation sector’s sustainability commitments and growing air travel volumes drive innovation in propylene glycol-based de-icing formulations. Research into more efficient, environmentally compatible de-icing fluids combined with FAA-mandated safety standards supports structural demand for propylene glycol in aviation ground operations.
The US propylene glycol value chain integrates petrochemical raw material supply, large-scale chemical synthesis, multi-grade purification, and diversified end-use distribution. The value chain’s commercial structure creates distinct pricing tiers from industrial-grade to food-grade and pharmaceutical-grade propylene glycol.
|
Stage |
Key Participants |
|
Raw Material Procurement |
Petroleum refinery operators and glycerol producers supplying propylene oxide and bio-based feedstocks to chemical synthesis facilities |
|
Chemical Synthesis |
Specialized chemical manufacturing units producing propylene glycol through hydrolysis and hydrogenolysis processes at commercial scale |
|
Purification & Grade Separation |
Refining and distillation facilities separating industrial, food-grade, and pharmaceutical-grade propylene glycol from production streams |
|
Quality Assurance & Compliance |
Internal and third-party quality control laboratories verifying compliance with applicable regulatory standards across all product grades |
|
Packaging & Logistics |
Bulk tanker operators, drum packaging facilities, and distribution network operators supplying industrial and commercial end users |
|
End-Use Manufacturing |
Processing facilities across transportation, food, pharmaceutical, cosmetics, and construction sectors consuming propylene glycol inputs |
The quality assurance and compliance stage is the most commercially significant, as pharmaceutical-grade propylene glycol commands a 30-50% price premium over industrial-grade. Regulatory certification requirements create barriers that differentiate premium-grade producers from commodity suppliers.
The dominant commercial production technology involves propylene oxide hydrolysis, where propylene oxide reacts with water to produce propylene glycol. Modern processes utilize advanced reactor designs and catalytic systems to improve conversion efficiency and reduce energy consumption at commercial scale.
Glycerol hydrogenolysis converts glycerol from biodiesel by-products into bio-based propylene glycol through catalytic hydrogenation. Ongoing R&D focuses on improving catalyst selectivity, glycerol conversion rates, and production economics to close the cost gap with petroleum-based propylene glycol production.
Advanced distillation and purification technologies enable separation of pharmaceutical, food-grade, and industrial-grade propylene glycol from a single production stream. Precision purification supports compliance with USP, EP, and FCC monographs required for pharmaceutical and cosmetics market access.
The report covers the following segments:
|
Segment Category |
Leading Segment |
Market Share |
Year |
| Source | Petroleum-based |
91.6% |
2025 |
|
Application |
Antifreeze and Functional Fluids |
31.7% |
2025 |
| End Use Industry | 🔒 | 🔒 | 2025 |
|
Region |
South |
42.8% |
2025 |
Petroleum-based propylene glycol leads at 91.6% (2025) through cost efficiency, established production infrastructure, and versatility across industrial, food-grade, and pharmaceutical-grade applications. The established propylene oxide hydrolysis technology supports consistent large-scale production volumes.

To access detailed market analysis, Request Sample
Bio-based at 8.4% is growing fastest (~7.2% CAGR) through federal sustainability mandates and corporate ESG procurement requirements. Strategic investments in glycerol hydrogenolysis capacity are expanding bio-based production volumes.
Antifreeze and functional fluids lead at 31.7% (2025), serving automotive coolant, aviation de-icing, and HVAC heat transfer markets. The transportation and aviation sectors provide consistent structural demand across all seasonal and geographic segments of the United States market.

Food, drug, and cosmetics at 24.8% represents the highest-margin application. Unsaturated polyester resins at 15.6% serve construction and marine composites. Liquid detergent at 11.9% and paints and coatings at 9.3% complete the commercial application landscape.
|
Region |
Share (2025) |
Key Market Characteristics |
|
South |
42.8% |
Dominant production and consumption region with concentrated chemical manufacturing infrastructure and high industrial activity supporting propylene glycol demand. |
|
Midwest |
21.6% |
Strong agricultural processing, food manufacturing, and automotive sector demand driving consistent propylene glycol consumption across the region. |
|
West |
20.7% |
Growing pharmaceutical and biotechnology manufacturing demand with increasing adoption of sustainable and bio-based chemical products. |
|
Northeast |
14.9% |
High pharmaceutical and personal care manufacturing concentration driving demand for premium food-grade and pharmaceutical-grade propylene glycol. |
The South’s 42.8% market leadership reflects the Gulf Coast petrochemical corridor’s concentration of production capacity. The Midwest’s 21.6% reflects agricultural-linked demand from food processing and grain operations.

The West’s 20.7% is driven by pharmaceutical manufacturing and state sustainability policies. The Northeast’s 14.9% reflects pharmaceutical and cosmetics manufacturing demand in metro industrial corridors.
The US propylene glycol market is moderately concentrated, with Dow Inc., BASF SE, and LyondellBasell Industries collectively accounting for an estimated 55-60% of domestic production capacity. Bio-based producers ADM and Cargill are gaining share in sustainability-driven segments, intensifying competitive dynamics.
|
Company |
Key Products/Brands |
Market Position |
Core Strength |
|
Dow |
Propylene Glycol |
Market Leader |
Vertically integrated propylene oxide and PG production; multi-grade portfolio; Gulf Coast manufacturing scale. |
|
BASF |
Propylene Glycol |
Strong Challenger |
Comprehensive PG grade range; pharmaceutical excipient leadership; North American distribution network. |
|
LyondellBasell Industries Holdings B.V. |
Propylene Glycol |
Strong Challenger |
Captive propylene oxide production advantage; large-scale US manufacturing; broad industrial customer base. |
|
ADM |
Propylene Glycol |
Innovator |
Pioneer in bio-based PG from renewable glycerol feedstocks; USDA BioPreferred certified production. |
Key players include Dow, BASF, LyondellBasell Industries Holdings B.V., ADM, and others.
Dow is one of the largest specialty chemical companies globally and a dominant producer of propylene glycol in the United States, operating integrated propylene oxide and propylene glycol production facilities across the Gulf Coast and supplying industrial, food-grade, and pharmaceutical-grade propylene glycol at commercial scale.
BASF is a leading global chemical company with a strong presence in the US propylene glycol market through its integrated chemical manufacturing and specialty chemical distribution network, supplying a broad range of propylene glycol grades and derivatives for industrial, pharmaceutical, and personal care applications.
The US propylene glycol market exhibits moderate concentration at the production level, with the leading three producers accounting for an estimated 55-60% of domestic production capacity. Market concentration is higher in pharmaceutical-grade supply, where FDA certification requirements create significant barriers to entry and limit the number of qualified suppliers available to regulated end users.
Market concentration is evolving through two competing forces. Established integrated chemical manufacturers maintain production dominance through scale advantages and capital-intensive infrastructure. Bio-based chemical producers are gradually increasing market share in sustainability-driven segments, creating a slow but structural shift in competitive dynamics that is expected to gradually reduce concentration over the forecast period as bio-based production capacity expands.
Bio-based propylene glycol represents the fastest-growing segment in the US market, projected to expand at a 7.2% CAGR during 2026–2034, followed by food, drug, and cosmetics applications at 5.8%, the South region is expected to grow at 5.1%, while antifreeze and functional fluids are projected to expand at 4.5%. Petroleum-based propylene glycol records the slowest growth at 4.1%, reflecting increasing demand for sustainable alternatives and expanding applications across consumer and industrial sectors.
Electric vehicle battery thermal management represents the highest-CAGR emerging application for propylene glycol. Battery pack cooling requirements in expanding US EV production create structured demand for non-toxic, high-performance heat transfer fluids, driving innovation and volume growth beyond traditional automotive antifreeze applications.
The US propylene glycol market is projected to grow from USD 1.16 Million in 2025 to USD 1.22 Million in 2026, reaching USD 1.48 Million by 2030 and USD 1.83 Million by 2034, at a CAGR of 4.88% during 2026-2034. The 2030 inflection point is driven by accelerating EV adoption and pharmaceutical manufacturing capacity expansion.
Three structural forces define market growth through 2034: domestic pharmaceutical manufacturing expansion creating sustained pharmaceutical-grade demand; EV thermal management establishing a new high-value application segment; and bio-based production scaling supported by USDA mandates and corporate ESG commitments, gradually shifting the source mix toward renewable feedstocks.
Primary research comprised structured interviews with US propylene glycol industry stakeholders including production plant managers, procurement directors at major end-user companies, supply chain executives, pharmaceutical excipient buyers, and regulatory compliance specialists across food-grade and industrial-grade markets.
Secondary research encompassed US chemical trade data, EPA production reports, FDA ingredient databases, company annual reports, USDA BioPreferred program data, ACC industry publications, and ICIS chemical market analysis. Over 50 secondary sources were systematically reviewed and cross-referenced for data validation.
Market revenue forecasts were developed using a bottom-up end-use demand model: US consumption volumes by application segment multiplied by average selling prices per grade, with source mix adjustments for petroleum-based versus bio-based production. CAGR was validated against historical production data and capacity expansion plans.
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2034 |
| Units | Million USD |
| Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
| Sources Covered | Petroleum-based, Bio-based |
| Applications Covered | Unsaturated Polyester Resins, Antifreeze and Functional Fluids, Food, Drug, and Cosmetics, Liquid Detergent, Paints and Coatings, Others |
| End Use Industries Covered | Transportation, Building and Construction, Food and Beverage, Pharmaceuticals, Cosmetics and Personal Care, Others |
| Regions Covered | Northeast, Midwest, South, West |
| Companies Covered | Dow, BASF, LyondellBasell Industries Holdings B.V., ADM, etc. |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The us propylene glycol market reached USD 1.16 Million in 2025. Demand spans antifreeze, pharmaceutical, food, and industrial chemical applications, with bio-based adoption and pharma reshoring supporting growth.
The us glycol market grows at 4.88% CAGR during 2026-2034, reaching USD 1.83 Million by 2034. Growth is sustained by pharmaceutical demand, EV thermal management, and consistent antifreeze consumption.
Petroleum-based propylene glycol leads at 91.6% through established production infrastructure and cost efficiency. Bio-based at 8.4% is the fastest-growing segment, driven by USDA mandates and sustainability demand.
Antifreeze and functional fluids lead at 31.7% through extensive use in automotive coolants, aviation de-icing, and HVAC systems. The US vehicle fleet and aviation activity sustain structural demand for this segment.
The South leads at 42.8% through Gulf Coast petrochemical production concentration in Texas and Louisiana. Strong industrial activity and regional distribution infrastructure reinforce this leadership.
Leading companies include Dow, BASF, LyondellBasell Industries Holdings B.V., ADM, and others.
The market is projected to reach USD 1.48 Million by 2030, with pharmaceutical-grade demand growing from domestic manufacturing expansion and EV thermal management emerging as a significant new application.
Three priority opportunities: bio-based production capacity expansion for the fastest-growing segment; pharmaceutical-grade supply for domestic drug manufacturing growth; and EV battery thermal management fluid development.
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
3 reports
5 reports
8 reports
10 reports